Segment Information (Tables)

6 Months Ended

Jun. 30, 2026

Segment Information

Schedule of segment reporting information, by segment

	Three Months Ended June 30,
	2026									2025
	Biopharm Division			Neurostimulation Division			Total			Biopharm Division			Neurostimulation Division			Total
Operating expenses:
Personnel and related expenses	$	2,638		$	310		$	2,948		$	2,587		$	298		$	2,885
Office space rental related expenses		915			34			949			1,077			96			1,173
Development expenses		983			-			983			1,243			-			1,243
Professional services and insurance		1,160			121			1,281			1,500			234			1,734
Depreciation		128			-			128			98			2			100
Other general and administrative expenses		499			86			585			220			107			327
Other (income) expense, net		(169)			(335)			(504)			(359)			41			(318)
Segment net loss	$	6,154		$	216		$	6,370		$	6,366		$	778		$	7,144

	Six Months Ended June 30,
	2026									2025
	Biopharm Division			Neurostimulation Division			Total			Biopharm Division			Neurostimulation Division			Total
Operating expenses:
Personnel and related expenses	$	5,248		$	700		$	5,948		$	5,060		$	519		$	5,579
Office space rental related expenses		2,043			64			2,107			2,140			206			2,346
Development expenses		1,991			-			1,991			2,070			-			2,070
Professional services and insurance		2,218			341			2,559			2,817			466			3,283
Depreciation		258			-			258			198			6			204
Other general and administrative expenses		786			172			958			382			156			538
Other (income) expense, net		(334)			(337)			(671)			(656)			82			(574)
Segment net loss	$	12,210		$	940		$	13,150		$	12,011		$	1,435		$	13,446